CF
FMI

C.T. Fitzpatrick’s Foundation Medicine, Inc. FMI Stock Holding History

C.T. Fitzpatrick’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-600
Closed -$16K – 107
2014
Q2 		$16K Buy
+600
New +$15.2K ﹤0.01% 98

Other funds holding FMI

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

C.T. Fitzpatrick's FMI Position: Q3 2014 in Review

C.T. Fitzpatrick sold out of Foundation Medicine, Inc. (FMI) in Q3 2014, closing a stake of 600 shares — an estimated $16K sold.

C.T. Fitzpatrick first reported a position in FMI in Q2 2014 and held it in 1 quarter. The position peaked at $16K in Q2 2014. 86 funds tracked by Wall St. Rank hold FMI as of Q3 2014.

  • C.T. Fitzpatrick reported no remaining Foundation Medicine, Inc. position as of Q3 2014 after selling out during the quarter.
  • C.T. Fitzpatrick sold 600 Foundation Medicine, Inc. shares in Q3 2014, an estimated $16K.
  • C.T. Fitzpatrick first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 1 quarter.
  • C.T. Fitzpatrick's Foundation Medicine, Inc. position peaked at $16K in Q2 2014.
  • 86 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2014.

Based on Vulcan Value Partners's 13F filing for Q3 2014, filed 7 Nov 2014.